Log in

NASDAQ:AZRXAzurRx BioPharma News Headlines

$0.84
-0.06 (-6.63 %)
(As of 05/26/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.83
Now: $0.85
$0.93
50-Day Range
$0.55
MA: $0.70
$0.92
52-Week Range
$0.37
Now: $0.85
$2.29
Volume222,698 shs
Average Volume427,499 shs
Market Capitalization$23.83 million
P/E RatioN/A
Dividend YieldN/A
Beta1.92

Headlines

AzurRx BioPharma (NASDAQ AZRX) News Headlines

Source:
DateHeadline
Zacks Investment Research Comments on AzurRx BioPharma Incs Q2 2020 Earnings (NASDAQ:AZRX)Zacks Investment Research Comments on AzurRx BioPharma Inc's Q2 2020 Earnings (NASDAQ:AZRX)
www.americanbankingnews.com - May 21 at 9:53 AM
AzurRx BioPharmas (AZRX) "Buy" Rating Reiterated at HC WainwrightAzurRx BioPharma's (AZRX) "Buy" Rating Reiterated at HC Wainwright
www.americanbankingnews.com - May 21 at 7:25 AM
Research Analysts Issue Forecasts for AzurRx BioPharma Incs Q3 2020 Earnings (NASDAQ:AZRX)Research Analysts Issue Forecasts for AzurRx BioPharma Inc's Q3 2020 Earnings (NASDAQ:AZRX)
www.americanbankingnews.com - May 20 at 9:23 AM
AzurRx BioPharma Inc (NASDAQ:AZRX) Short Interest Down 22.1% in MayAzurRx BioPharma Inc (NASDAQ:AZRX) Short Interest Down 22.1% in May
www.americanbankingnews.com - May 19 at 8:43 AM
Zacks: Brokerages Expect AzurRx BioPharma Inc (NASDAQ:AZRX) to Post -$0.11 Earnings Per ShareZacks: Brokerages Expect AzurRx BioPharma Inc (NASDAQ:AZRX) to Post -$0.11 Earnings Per Share
www.americanbankingnews.com - May 14 at 2:38 AM
AzurRx BioPharma Inc (NASDAQ:AZRX) Sees Large Growth in Short InterestAzurRx BioPharma Inc (NASDAQ:AZRX) Sees Large Growth in Short Interest
www.americanbankingnews.com - May 11 at 8:10 PM
AzurRx BioPharma Announces Entry into Packaging, Labeling and Distribution Agreement with Creapharm Clinical Supplies for MS1819 Clinical Trial Drug ProductAzurRx BioPharma Announces Entry into Packaging, Labeling and Distribution Agreement with Creapharm Clinical Supplies for MS1819 Clinical Trial Drug Product
finance.yahoo.com - May 7 at 5:03 PM
AzurRx BioPharma Receives Approximately $721,000 for its 2019 CIR (French Research Tax Credit)AzurRx BioPharma Receives Approximately $721,000 for its 2019 CIR (French Research Tax Credit)
finance.yahoo.com - May 5 at 8:19 AM
What Kind Of Share Price Volatility Should You Expect For AzurRx BioPharma, Inc. (NASDAQ:AZRX)?What Kind Of Share Price Volatility Should You Expect For AzurRx BioPharma, Inc. (NASDAQ:AZRX)?
finance.yahoo.com - May 4 at 7:58 AM
AzurRx BioPharma Receives Insititutional Review Board Approval to Commence its Phase 2 OPTION 2 Clinical Trial of MS1819 in Cystic FibrosisAzurRx BioPharma Receives Insititutional Review Board Approval to Commence its Phase 2 OPTION 2 Clinical Trial of MS1819 in Cystic Fibrosis
finance.yahoo.com - April 30 at 5:26 PM
AzurRx up 7% in inclusion of TDN sites in cystic fibrosis studyAzurRx up 7% in inclusion of TDN sites in cystic fibrosis study
seekingalpha.com - April 29 at 2:31 PM
AzurRx BioPharma Receives Approval to Conduct its Phase 2 OPTION 2 Clinical Trial of MS1819 in Cystic Fibrosis Therapeutics Development Network SitesAzurRx BioPharma Receives Approval to Conduct its Phase 2 OPTION 2 Clinical Trial of MS1819 in Cystic Fibrosis Therapeutics Development Network Sites
finance.yahoo.com - April 29 at 9:30 AM
AzurRx BioPharma Issues Letter to ShareholdersAzurRx BioPharma Issues Letter to Shareholders
finance.yahoo.com - April 21 at 12:43 PM
Argus Research Initiates Equity Research Report Coverage on AzurRx BioPharma, Inc. (NasdaqCM: AZRX)Argus Research Initiates Equity Research Report Coverage on AzurRx BioPharma, Inc. (NasdaqCM: AZRX)
finance.yahoo.com - April 21 at 1:37 AM
Argus Research Initiates Equity Research Report Coverage on AzurRx BioPharma, Inc. (NasdaqCM: AZRX)Argus Research Initiates Equity Research Report Coverage on AzurRx BioPharma, Inc. (NasdaqCM: AZRX)
finance.yahoo.com - April 20 at 3:35 PM
AzurRx Announces Manufacturing Agreement with Delpharm for MS1819 Clinical Drug ProductAzurRx Announces Manufacturing Agreement with Delpharm for MS1819 Clinical Drug Product
finance.yahoo.com - April 16 at 2:55 PM
AzurRx BioPharma, Inc.: AzurRx BioPharma to Present at the Planet MicroCap Showcase Virtual Investor Conference 2020AzurRx BioPharma, Inc.: AzurRx BioPharma to Present at the Planet MicroCap Showcase Virtual Investor Conference 2020
www.finanznachrichten.de - April 15 at 1:06 PM
AzurRx BioPharma to Present at the Planet MicroCap Showcase Virtual Investor Conference 2020AzurRx BioPharma to Present at the Planet MicroCap Showcase Virtual Investor Conference 2020
finance.yahoo.com - April 15 at 1:06 PM
AzurRx Appoints Gregory Oakes to its Board of DirectorsAzurRx Appoints Gregory Oakes to its Board of Directors
finance.yahoo.com - April 9 at 10:52 AM
AzurRx BioPharma Receives $642,000 for its 2017 CIR (French Research Tax Credit)AzurRx BioPharma Receives $642,000 for its 2017 CIR (French Research Tax Credit)
finance.yahoo.com - April 1 at 3:35 PM
AzurRx BioPharma Inc.AzurRx BioPharma Inc.
www.marketwatch.com - March 27 at 9:50 PM
AzurRx BioPharma to Present at the New York City based Investor Summit on March 25th-26thAzurRx BioPharma to Present at the New York City based Investor Summit on March 25th-26th
finance.yahoo.com - March 18 at 12:18 PM
AzurRx BioPharma Receives $1.13 million in 2018 CIR (French Research Tax Credit)AzurRx BioPharma Receives $1.13 million in 2018 CIR (French Research Tax Credit)
finance.yahoo.com - March 2 at 8:54 AM
AzurRx BioPharma Announces Presentation of Phase II MS1819 Data in Cystic Fibrosis at the 2020 Digestive Disease Week ConferenceAzurRx BioPharma Announces Presentation of Phase II MS1819 Data in Cystic Fibrosis at the 2020 Digestive Disease Week Conference
finance.yahoo.com - February 18 at 12:32 PM
BRIEF-Azurrx Biopharma Inc Files Prospectus Relates To Offer, Sale Of Up To 11.6 Million Shares Of Common Stock By Certain Of ShareholdersBRIEF-Azurrx Biopharma Inc Files Prospectus Relates To Offer, Sale Of Up To 11.6 Million Shares Of Common Stock By Certain Of Shareholders
www.reuters.com - February 7 at 6:16 PM
AZRX: EPI Treatment in the NewsAZRX: EPI Treatment in the News
finance.yahoo.com - February 3 at 6:22 PM
Alexander Capital, L.P. Serves as Sole Placement Agent in $6.9 Million Financing for AzurRx BioPharma, Inc.Alexander Capital, L.P. Serves as Sole Placement Agent in $6.9 Million Financing for AzurRx BioPharma, Inc.
finance.yahoo.com - January 13 at 9:53 PM
AzurRx BioPharma Announces Closing of $6.9 Million Private PlacementAzurRx BioPharma Announces Closing of $6.9 Million Private Placement
finance.yahoo.com - January 13 at 4:52 PM
AzurRx Bio up 33% ahead of MS1819-SD dataAzurRx Bio up 33% ahead of MS1819-SD data
seekingalpha.com - January 10 at 3:32 PM
AzurRx BioPharma To Present Interim Phase 2...AzurRx BioPharma To Present Interim Phase 2...
www.benzinga.com - January 9 at 9:28 PM
AzurRx BioPharma To Present Interim Phase 2 Clinical Study Data for MS1819-SD, in combination with standard PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency, at Biotech Showcase 2020 Conference (January 13) in San FranciscoAzurRx BioPharma To Present Interim Phase 2 Clinical Study Data for MS1819-SD, in combination with standard PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency, at Biotech Showcase 2020 Conference (January 13) in San Francisco
finance.yahoo.com - January 9 at 9:28 PM
AzurRx BioPharma to Present at the Biotech Showcase 2020 Conference (January 13th)AzurRx BioPharma to Present at the Biotech Showcase 2020 Conference (January 13th)
finance.yahoo.com - January 6 at 4:11 PM
New finance chief at AzurRx BioNew finance chief at AzurRx Bio
seekingalpha.com - January 3 at 4:51 PM
AZRX: 3Q:19 ReviewAZRX: 3Q:19 Review
finance.yahoo.com - November 26 at 8:21 PM
AZRX: 3Q:19 ReviewAZRX: 3Q:19 Review
finance.yahoo.com - November 26 at 8:21 PM
AzurRx BioPharma, Inc. Common Stock (AZRX) Earnings Report DateAzurRx BioPharma, Inc. Common Stock (AZRX) Earnings Report Date
www.nasdaq.com - November 15 at 3:51 AM
BRIEF-Azurrx Biopharma Announces Equity Purchase Agreement For Up To $15 Mln With Lincoln Park Capital FundBRIEF-Azurrx Biopharma Announces Equity Purchase Agreement For Up To $15 Mln With Lincoln Park Capital Fund
www.msn.com - November 14 at 10:51 PM
AzurRx up 31% on stock purchase dealAzurRx up 31% on stock purchase deal
seekingalpha.com - November 14 at 12:50 PM
AzurRx BioPharma, Inc. Announces Equity Purchase Agreement for up to $15 Million with Lincoln Park Capital Fund, LLCAzurRx BioPharma, Inc. Announces Equity Purchase Agreement for up to $15 Million with Lincoln Park Capital Fund, LLC
finance.yahoo.com - November 14 at 12:50 PM
AzurRx BioPharma CEO Issues Letter to ShareholdersAzurRx BioPharma CEO Issues Letter to Shareholders
finance.yahoo.com - October 22 at 1:55 PM
BRIEF-Azurrx Biopharma Announces Positive Cff Dsmb Review Of Final Phase 2 Option Trial DataBRIEF-Azurrx Biopharma Announces Positive Cff Dsmb Review Of Final Phase 2 Option Trial Data
www.msn.com - October 17 at 11:38 PM
AzurRx BioPharma Announces Positive CFF DSMB Review of Final Phase 2 OPTION Trial DataAzurRx BioPharma Announces Positive CFF DSMB Review of Final Phase 2 OPTION Trial Data
finance.yahoo.com - October 17 at 1:38 PM
AzurRx Bio launches mid-stage MS1819-SD study in combination with PERTAzurRx Bio launches mid-stage MS1819-SD study in combination with PERT
seekingalpha.com - October 15 at 1:25 PM
AzurRx BioPharma Announces First Patients Dosed in Clinical Study for MS1819-SD in combination with PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic InsufficiencyAzurRx BioPharma Announces First Patients Dosed in Clinical Study for MS1819-SD in combination with PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency
finance.yahoo.com - October 15 at 8:24 AM
AzurRx BioPharma Announces Appointment of James Sapirstein as Chief Executive OfficerAzurRx BioPharma Announces Appointment of James Sapirstein as Chief Executive Officer
finance.yahoo.com - October 10 at 8:27 AM
AZRX: OPTION Trial ReadoutAZRX: OPTION Trial Readout
finance.yahoo.com - October 1 at 3:29 PM
AzurRx Shares Tank On Unimpressive Efficacy Data For Biologic Drug To Treat Pancreatic InsufficiencyAzurRx Shares Tank On Unimpressive Efficacy Data For Biologic Drug To Treat Pancreatic Insufficiency
finance.yahoo.com - September 25 at 4:15 PM
AzurRx BioPharma Announces Positive Results from Phase 2 Trial with MS1819 in Cystic Fibrosis PatientsAzurRx BioPharma Announces Positive Results from Phase 2 Trial with MS1819 in Cystic Fibrosis Patients
finance.yahoo.com - September 25 at 8:07 AM
AZRX: OPTION & Combo Trial UnderwayAZRX: OPTION & Combo Trial Underway
finance.yahoo.com - August 26 at 6:09 PM
AzurRx BioPharma Reports Second Quarter 2019 Financial Results and Provides Corporate UpdateAzurRx BioPharma Reports Second Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - August 13 at 6:31 PM
This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.